Table 1.
Prevalence of metabolic syndrome (MetS) among patients with cancer; Nationwide Inpatient Sample 2007–2011
| Metabolic syndrome present N (%) | |||
|---|---|---|---|
|
| |||
| Breast cancer | Colorectal cancer | Prostate cancer | |
| N | 70,916 | 152,952 | 87,623 |
| Overall with MetS | 3702 (5.22) | 10,543 (6.89) | 4777 (5.45) |
| Age (years) | |||
| 40–49 | 210 (1.43) | 360 (2.62) | 108 (2.87) |
| 50–59 | 730 (1.03) | 1612 (5.33) | 1048 (4.39) |
| 60–69 | 1278 (7.34) | 3215 (8.57) | 2339 (6.25) |
| 70 and above | 1484 (7.26) | 5356 (7.50) | 1282 (5.68) |
| Gender | |||
| Females | - | 5148 (6.79) | - |
| Males | - | 5395 (6.99) | - |
| Race | |||
| Whites | 2307 (4.51) | 7558 (6.71) | 3254 (4.91) |
| Blacks | 798 (8.63) | 1434 (7.36) | 874 (7.58) |
| Hispanics | 361 (6.19) | 887 (7.79) | 376 (6.90) |
| Others | 236 (5.36) | 664 (7.02) | 273 (6.22) |
| Region | |||
| Large metropolitan | 2218 (5.26) | 5688 (6.79) | 2655 (5.46) |
| Small metropolitan | 876 (4.95) | 2803 (7.05) | 1283 (5.20) |
| Micropolitan | 355 (5.44) | 1161 (6.94) | 505 (5.84) |
| Non-metro non-micropolitan | 253 (5.58) | 891 (7.06) | 334 (5.88) |
| Area-level income | |||
| Q4-highest | 831 (4.09) | 2249 (6.38) | 1264 (4.73) |
| Q3 | 875 (5.16) | 2601 (7.19) | 1267 (5.69) |
| Q2 | 919 (5.58) | 2710 (6.94) | 1166 (5.77) |
| Q1-lowest | 1077 (6.28) | 2983 (7.01) | 1080 (5.85) |
| Insurance | |||
| Medicare | 2133 (7.56) | 6901 (8.01) | 2294 (6.39) |
| Medicaid | 349 (4.86) | 493 (4.49) | 109 (4.99) |
| Private | 1101 (3.42) | 2753 (5.98) | 2192 (4.79) |
| Other | 119 (3.54) | 396 (4.05) | 182 (4.83) |
| Discharge disposition | |||
| Routine discharge | 1764 (4.40) | 5223 (6.77) | 3213 (5.15) |
| Skilled nursing facility | 966 (6.78) | 3048 (7.40) | 458 (6.31) |
| Expired | 19 (1.68) | 123 (2.83) | 10 (1.43) |
| Other | 953 (6.16) | 2149 (7.10) | 1096 (6.32) |
| Metastasis | |||
| Non-metastatic | 2665 (5.43) | 7398 (7.79) | 4447 (5.54) |
| Metastatic | 1037 (4.75) | 3145 (5.43) | 330 (4.60) |
| Cancer surgery* | |||
| No | 1930 (5.06) | 4444 (6.28) | 4777 (5.45) |
| Yes | 1772 (5.40) | 6099 (7.82) | - |
| Complications | |||
| No | 3490 (5.17) | 8474 (6.96) | 4404 (5.37) |
| Yes | 212 (6.31) | 2069 (6.65) | 373 (6.71) |
| No. of comorbiditiesa | 0.49 (0.73) | 0.59 (0.81) | 0.34 (0.62) |
| Length of stay | 2.80 (3.06) | 7.11 (6.47) | 2.62 (2.48) |
a
Mean and standard deviation reported
b
Comorbidities assessed based on ICD9 codes for the following: myocardial infarction, chronic heart failure, peripheral vascular disease, cerebrovascular disease, dementia, cardio-pulmonary disease, rheumatic disease, peptic ulcer disease, mild liver disease, hemiplegia, paraplegia, renal disease, liver disease, and HIV/AIDS
Row percent
Frequencies do not add up due to missing data